Your Feedback Drives Change

It is simply devastating for cancer patients to have targeted therapy drugs withdrawn – especially when it is unknown when a replacement will become available, as in the case of Mobocertinib. It is essential that alternative therapies are made available as soon as possible, to help people live well, for longer.

The drug approval process is rightly thorough but can be extremely expensive and time-consuming. This challenge is then further exacerbated as ‘personalised’ medicines target smaller and smaller subpopulations.

We need a new solution to help improve this: one that helps Pharmaceutical companies to navigate the complexities of the drug approvals process at a faster pace, for less cost and at the same time dramatically improve the quality of information (and the data that NICE are saying they want collecting).

DaSH Global / Your Health Companion wants to help achieve this by collecting patient reported outcomes directly from people living with the disease, that can be used in research to accelerate access to new drugs.

Integrating Patient Reported Outcomes data into the drug development and evaluation process can enhance the understanding of a cancer drug's benefits and risks, facilitate regulatory approval, inform reimbursement decisions, support informed treatment decisions by healthcare providers, and ultimately expedite access to new cancer drugs for patients.

By downloading and recording your data YHC you can help drive research and change - and ultimately your voice can help speed up access to new drugs.

We encourage patients to sign up for Your Health Companion today:

It is easy to get started and each month, it takes just 10 minutes to complete. Either download from your App store – search for ‘Your Health Companion’ - or use on your desktop computer via this website: www.health-companion.me